Cargando…
EPICE-HIV: An Epidemiologic Cost-Effectiveness Model for HIV Treatment
The goal of this research was to establish a new and innovative framework for cost-effectiveness modeling of HIV-1 treatment, simultaneously considering both clinical and epidemiological outcomes. EPICE-HIV is a multi-paradigm model based on a within-host micro-simulation model for the disease progr...
Autores principales: | Vandewalle, Björn, Llibre, Josep M., Parienti, Jean-Jacques, Ustianowski, Andrew, Camacho, Ricardo, Smith, Colette, Miners, Alec, Ferreira, Diana, Félix, Jorge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752501/ https://www.ncbi.nlm.nih.gov/pubmed/26870960 http://dx.doi.org/10.1371/journal.pone.0149007 |
Ejemplares similares
-
Projected Lifetime Healthcare Costs Associated with HIV Infection
por: Nakagawa, Fumiyo, et al.
Publicado: (2015) -
Assessment of the Potential Impact and Cost-effectiveness of Self-Testing for HIV in Low-Income Countries
por: Cambiano, Valentina, et al.
Publicado: (2015) -
Hidden costs of HIV treatment in Spain: inefficiency of the antiretroviral drug packaging
por: Llibre-Codina, Josep M, et al.
Publicado: (2014) -
HIV and SARS-CoV-2 Co-infection: Epidemiological, Clinical Features, and Future Implications for Clinical Care and Public Health for People Living with HIV (PLWH) and HIV Most-at-Risk Groups
por: Nomah, Daniel K, et al.
Publicado: (2021) -
Risk and Cost Associated With Drug–Drug Interactions Among Aging HIV Patients Receiving Combined Antiretroviral Therapy in France
por: Demessine, Ludivine, et al.
Publicado: (2019)